Sight Sciences (SGHT) Liabilities and Shareholders Equity (2020 - 2026)

Sight Sciences' Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $109.7 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 15.41% year-over-year to $109.7 million; the TTM figure through Mar 2026 stood at $463.2 million (down 18.13% YoY), while the FY2025 annual figure was $115.3 million, down 19.28% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $109.7 million, down from $115.3 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $258.6 million in Q1 2022, with the low at $109.7 million in Q1 2026.
• The 5-year median for Liabilities and Shareholders Equity is $155.6 million (2024), against an average of $167.5 million.
• The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity soared 358.48% in 2022, then declined 23.96% in 2023.
• Sight Sciences' Liabilities and Shareholders Equity stood at $213.1 million in 2022, then slipped by 21.79% to $166.7 million in 2023, then fell by 14.29% to $142.8 million in 2024, then fell by 19.28% to $115.3 million in 2025, then dropped by 4.86% to $109.7 million in 2026.
• Business Quant data shows SGHT's Liabilities and Shareholders Equity at $109.7 million in Q1 2026, $115.3 million in Q4 2025, and $116.3 million in Q3 2025.